Please login to the form below

Not currently logged in
Email:
Password:

Cidara Therapeutics makes senior appointments

Paul Daruwala and James Balkovec join the biotech

edit-Cidara-Paul-DaruwalaBiotech Cidara Therapeutics has named Paul Daruwala as chief commercial officer and James Balkovec as senior VP of research.

Daruwala (pictured) has over 22 years of experience in the biopharma industry and will lead Cidara's commercial and business development strategies and execution.

He joins from BMS, where he served as VP of the US viral hepatitis franchise, which is responsible for leading the US launch platform in hepatitis C and running the hepatitis B business for Baraclude.

Prior to BMS, Daruwala spent 18 years at Merck in a range of US and global commercial leadership roles in areas including anti-inflammatory products, business development and sales management.

Balkovec has over 28 years of experience in the biopharma industry and has extensive experience within drug discovery. He also joins from Merck, where he has served as senior scientific director and team leader, managing programmes in areas including infectious disease, metabolic syndrome and thrombosis disease.

Balkovec has helped bring more than a dozen development candidates into clinical development, including the first approved echinocandin antifungal drug Cancidas (caspofungin), which he is additionally co-inventor of.

Cidara focuses on the discovery, development and commercialisation of novel anti-infectives for the treatment of diseases that are not adequately addresses by current available therapies.

2nd March 2015

From: Research, Sales

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Say Communications

Influencing positive behaviours and delivering change is what drives us, using thought leadership, education, social and professional engagement and compelling,...

Latest intelligence

Covid-19 redefines rules of customer engagement
Oli Hudson, Content Director at Wilmington Healthcare, explores how the pandemic has changed pharma’s relationship with HCPs...
Ongoing Virtual Communication between MSLs and Physicians: a Customer Story
Learn how one of our clients used the Impetus InSite Platform to connect their MSLs with regional groups of physicians....
The concordance conundrum: understanding the complexities of behaviour change
Understanding behaviour change looks at the six fundamental steps required to change human behaviour and discusses why HCPs need to start here if concordance is to be improved....

Infographics